Oscar Health, Inc. (NYSE:OSCR) shares are touching fresh 52-week highs Wednesday, extending a remarkable 80% year-to-date run as investors digest Monday’s guidance reaffirmation at the Goldman Sachs Healthcare Conference.
The Conference Catalyst
Monday’s move was driven by a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference, where Oscar management reaffirmed its full-year 2026 guidance and disclosed that the year was progressing strongly. The company cited favorable trends and lighter-than-expected market morbidity — essentially telling investors that medical costs are coming in better than feared. For a health insurer, that’s the most important thing the market wants to hear. Shares jumped 10.8% on the session, hitting an intraday high of $27.66 before closing at $27.39.
The Q1 Foundation
The conference catalyst didn’t come out of nowhere. Oscar’s first-quarter earnings report on May 6 was the strongest in the company’s history — the company swung to a $679 million profit, membership surged 56% year over year to 3.17 million, and the medical loss ratio improved sharply to 70.5% from 75.4% a year earlier. Earnings per share came in at $2.07 — more than double the $1.01 analyst estimate. Revenue rose to $4.65 billion from $3.05 billion. The quarter gave investors genuine fundamental reasons to reassess the stock, and the run has continued ever since.
Oscar Shares Edge Higher
OSCR Price Action: At the time of publication, Oscar shares are trading 4.81% higher at $28.53, according to data from Benzinga Pro.
Image via Shutterstock
